Contact this trialFirst, we need to learn more about you.
Ocrelizumab Exposure During Pregnancy for Multiple Sclerosis
Recruiting3 awardsPhase 4
New York, New York
This trial will study the transfer of the drug ocrelizumab to the fetus through the placenta in pregnant women with clinically isolated syndrome or multiple sclerosis, and the effects of the drug on infants.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.